intestinal

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a … – 7thSpace Interactive (press release)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a …7thSpace Interactive (press release)There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and…